← CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.7b | $1.9b | $2.3b | $2.6b | $2.9b | $3.5b | $4.0b | $4.1b | $4.0b | $4.0b | |
| Cost of Goods and Services Sold | $277.0m | $289.7m | $1.5b | $1.8b | $2.0b | $2.3b | $2.7b | $2.8b | $3.1b | $3.2b | |
| Gross Profit (Calculated) (derived) | $1.4b | $1.6b | $775.2m | $868.8m | $961.7m | $1.2b | $1.3b | $1.4b | $978.4m | $768.2m | |
| Operating Income (Loss) | $237.4m | $287.5m | $331.4m | $351.2m | $432.7m | $589.9m | $651.0m | $617.3m | $227.3m | $25.2m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $41.7m | $41.4m | $64.8m | $89.5m | $111.9m | $124.9m | $146.6m | $137.4m | $138.5m | $179.1m | |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | — | — | — | — | — | — | $17.4m | |
| Goodwill, Impairment Loss | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $215.0m | $165.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $59.3m | $123.9m | $95.1m | $108.3m | $226.9m | $129.6m | $280.1m | $185.7m | ($290.3m) | ($290.6m) | |
| Income (Loss) from Continuing Operations, Per Basic Share | $3 | $3 | $5 | $5 | $7 | $8 | $10 | $9 | $0 | ($3) | |
| Income (Loss) from Continuing Operations, Per Diluted Share | $3 | $3 | $5 | $5 | $7 | $8 | $10 | $9 | $0 | ($3) | |
| Investment Income, Interest | $1.3m | $690k | $812k | $1.5m | $834k | $652k | $780k | $5.2m | $8.6m | $4.9m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $222.9m | $297.0m | $281.7m | $304.1m | $447.1m | $480.7m | $623.0m | $581.3m | $93.1m | ($99.5m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $156.1m | $125.6m | $227.2m | $254.1m | $365.3m | $7.9m | $6.4m | $5.7m | $3.1m | $2.2m | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $280k | ($137k) | $1.5m | $0 | $0 | — | — | — | $3.1m | $2.2m | |
| Net Income (Loss) Attributable to Parent | $154.8m | $123.4m | $226.4m | $252.0m | $364.3m | $391.0m | $486.2m | $474.6m | $22.2m | ($144.3m) | |
| Net Income (Loss) Available to Common Stockholders, Basic | $154.8m | $123.4m | $226.4m | $252.0m | $364.3m | $391.0m | $486.2m | $474.6m | $10.3m | ($144.3m) | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.6m | $2.1m | $2.4m | $2.0m | $1.0m | $7.9m | $6.4m | $5.7m | $3.1m | $2.2m | |
| Earnings Per Share, Basic | $3.29 | $2.60 | $4.72 | $5.17 | $7.35 | $7.77 | $9.57 | $9.27 | $0.20 | ($2.91) | |
| Earnings Per Share, Diluted | $3.23 | $2.54 | $4.62 | $5.07 | $7.20 | $7.60 | $9.48 | $9.22 | $0.20 | ($2.91) | |
| Weighted Average Number of Shares Outstanding, Basic | 47.0m | 47.5m | 47.9m | 48.7m | 49.5m | 50.3m | 50.8m | 51.2m | 51.4m | 49.6m | |
| Weighted Average Number of Shares Outstanding, Diluted | 48.0m | 48.6m | 49.0m | 49.7m | 50.6m | 51.4m | 51.3m | 51.5m | 51.6m | 49.6m | |
| Selling, General and Administrative Expense | $367.5m | $373.4m | $443.9m | $517.6m | $528.9m | $619.9m | $665.1m | $747.9m | $751.0m | $743.1m | |
| Other Nonoperating Income (Expense) | $11.9m | $38.5m | $13.3m | $12.3m | $100.0m | ($35.9m) | $30.5m | $95.5m | ($16.5m) | ($22.6m) | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $126.3m | $107.0m | |
| Current Income Tax Expense (Benefit) | $63.7m | $143.4m | $64.8m | $71.5m | $80.2m | $102.2m | $163.5m | $152.3m | $135.0m | $118.0m | |
| Interest Expense | $27.7m | $29.8m | $63.8m | $60.9m | $86.4m | $73.9m | $59.3m | $136.7m | $126.3m | $107.0m | |
| Restructuring and Related Cost, Incurred Cost | — | $4.3m | $8.7m | $12.7m | $9.3m | $5.7m | — | $11.5m | — | — | |
| Income Tax Expense (Benefit) | $66.8m | $171.4m | $54.5m | $50.0m | $81.8m | $81.9m | $130.4m | $100.9m | $67.8m | $42.7m | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | $0 | $0 | — | — | — | — | — | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.